Literature DB >> 8288715

Clinical review 53: The endocrinology of vasoactive peptides: synthesis to function.

S A Rubin1, E R Levin.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8288715     DOI: 10.1210/jcem.78.1.8288715

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Should obesity be treated? Obesity is an anaesthetic risk.

Authors:  A P Lake; E G Williams
Journal:  BMJ       Date:  1994-10-29

2.  Sensitization to acute procedural pain in pediatric sickle cell disease: modulation by painful vaso-occlusive episodes, age, and endothelin-1.

Authors:  Alyssa M Schlenz; Catherine B McClellan; Teresa R M Mark; Alvin D McKelvy; Eve Puffer; Carla W Roberts; Sarah M Sweitzer; Jeffrey C Schatz
Journal:  J Pain       Date:  2012-05-24       Impact factor: 5.820

Review 3.  Endothelin-1 as a target for therapeutic intervention in prostate cancer.

Authors:  E Scott Kopetz; Joel B Nelson; Michael A Carducci
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

4.  Role of atrial natriuretic peptide in the development of arterial hypertension in patients with pubertal hypothalamic syndrome.

Authors:  T P Krivchenko; N I Verbovaya
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

Review 5.  New concepts in nutraceuticals as alternative for pharmaceuticals.

Authors:  Hamid Nasri; Azar Baradaran; Hedayatollah Shirzad; Mahmoud Rafieian-Kopaei
Journal:  Int J Prev Med       Date:  2014-12

6.  Endothelin receptors as novel targets in tumor therapy.

Authors:  Anna Bagnato; Pier Giorgio Natali
Journal:  J Transl Med       Date:  2004-05-27       Impact factor: 5.531

Review 7.  Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain.

Authors:  Terika P Smith; Tami Haymond; Sherika N Smith; Sarah M Sweitzer
Journal:  J Pain Res       Date:  2014-08-30       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.